Please login to the form below

Not currently logged in
Email:
Password:

SkinMedica

This page shows the latest SkinMedica news and features for those working in and with pharma, biotech and healthcare.

Allergan inks $2.1bn deal to buy cosmetic drug firm Kythera

Allergan inks $2.1bn deal to buy cosmetic drug firm Kythera

sales channels already in place for wrinkle treatment Botox and its dermal filler products Voluma, JuveDerm and SkinMedica. .

Latest news

  • Feverish activity

    NeoBenz (SkinMedica). Treatment of acne vulgaris. US. Leuprorelin. Eligard (MediGene AG).

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2012 Pharma deals during November 2012

    SkinMedica's topical aesthetics skincare business includes a variety of "physician dispensed" non-prescription and prescription products that sit more comfortably with Allergan's “wrinkle reducers” Botox and Juvederm. The Colorescience

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics